MedTrace Logo

Prospective Evaluation to Characterize the Real-World Performance of the EMBOVAC Aspiration Catheter

NCT04531904 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 102

Last updated 2024-01-26

Study results available
· View outcomes & findings →

Summary

A post-market study evaluating the EMBOVAC Aspiration Catheter in acute ischemic stroke patients with confirmed intracranial large vessel occlusion.

Conditions

  • Acute Ischemic Stroke

Interventions

DEVICE

EMBOVAC Aspiration Catheter

The EMBOVAC Aspiration catheter is used to treat acute ischemic stroke. The catheter can be used to facilitate introduction of diagnostic or therapeutic agents and is also intended for use in removal/aspiration of emboli and thrombi from selected blood vessels in the neuro vasculature.

Sponsors & Collaborators

  • Cerenovus, Part of DePuy Synthes Products, Inc.

    lead INDUSTRY

Principal Investigators

  • Kyriakos Lobotesis · Imperial College Healthcare NHS Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-15
Primary Completion
2022-05-02
Completion
2022-07-26

Countries

  • Germany
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04531904 on ClinicalTrials.gov